Literature DB >> 29603516

A PIGH mutation leading to GPI deficiency is associated with developmental delay and autism.

Thi Tuyet Mai Nguyen1, Sonal Mahida2, Constance Smith-Hicks2, Philippe M Campeau1,3.   

Abstract

We identified an individual with a homozygous missense variant (p.Ser103Pro) in a conserved residue of the glycosylphosphatidylinositol (GPI) biosynthesis gene PIGH. This gene encodes an essential component of the phosphatidylinositol N-acetylglucosaminyltransferase complex, in the first step of the biosynthesis of GPI, a glycolipid anchor added to more than one hundred human proteins, several being critical for embryogenesis and neurological functions. The affected individual had hypotonia, moderate developmental delay, and autism. Unlike other reported individuals with GPI deficiency, the proband did not have epilepsy; however, he did have two episodes of febrile seizures. He had normal alkaline phosphatase and no brachytelephalangy. Upon analysis of the surface expression of GPI-anchored proteins on granulocytes, he was demonstrated to have GPI deficiency. This suggests that PIGH mutations may cause a syndrome with developmental delay and autism, but without an epileptic encephalopathy, and should increase the awareness of the potentially deleterious nature of biallelic variants in this gene.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  GPI; PIGH; developmental delay; exome; glycosylphosphatidylinositol

Mesh:

Substances:

Year:  2018        PMID: 29603516     DOI: 10.1002/humu.23426

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  2 in total

1.  Homozygous variant p.(Arg163Trp) in PIGH causes glycosylphosphatidylinositol biosynthesis defect with epileptic encephalopathy and delayed myelination.

Authors:  Michelle C do Rosario; Parneet Kaur; Katta Mohan Girisha; Stephanie Bielas; Anju Shukla
Journal:  Clin Dysmorphol       Date:  2022-04-19       Impact factor: 0.884

2.  PIGH deficiency can be associated with severe neurodevelopmental and skeletal manifestations.

Authors:  Camille Tremblay-Laganière; Rauan Kaiyrzhanov; Reza Maroofian; Thi Tuyet Mai Nguyen; Kamran Salayev; Ilana T Chilton; Wendy K Chung; Jill A Madden; Chanika Phornphutkul; Pankaj B Agrawal; Henry Houlden; Philippe M Campeau
Journal:  Clin Genet       Date:  2020-11-27       Impact factor: 4.296

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.